| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |